Page 2 - Essential Pharma News Today

All the latest breaking news on NHS. Browse ibtimes archives of photos, videos and articles on NHS.

/PRNewswire/ -- Essential Pharma, an international speciality pharma group focused on maintaining access to well-established, "at risk" products essential to...

/PRNewswire/ -- Essential Pharma, an international speciality pharma group focused on maintaining access to well-established, "at risk" products essential to...

/PRNewswire/ -- Essential Pharma, an international speciality pharma group focused on maintaining access to well-established, "at risk" products essential to...

A quick look at the key legal and regulatory provisions governing abuse of dominance in United Kingdom, including the types of conduct that constitute abuse and available defences.

Essential Pharma, an international specialty pharma group focused on maintaining access to well-established, “at risk” products essential to patients across multiple therapeutic areas, announces the closing of two transactions with Rosemont Pharmaceuticals (“Rosemont”). Essential Pharma has completed the ...

- Divestments of UK oral liquid products streamlines the portfolio and furthers Essential Pharma's international growth strategy - Acquired products are low volume, but essential medicines

Essential Pharma Appoints Steen Vangsgaard As Chief Executive Officer News provided by Share this article Share this article EGHAM, England, May 10, 2021 /PRNewswire/ -- Essential Pharma, an international specialty pharma company focused on maintaining access to well-established, "at risk" products essential to patients across multiple therapeutic areas, announces the appointment of Steen Vangsgaard as Chief Executive Officer. Steen has more than 20 years of experience in the specialty pharma ...

Essential Pharma Appoints Pharma and Healthcare Operations Expert Colin Brown As Chief Operating Officer News provided by Share this article Share this article EGHAM, England, Feb. 9, 2021 /PRNewswire/ -- Essential Pharma, an international pharmaceutical generics company dedicated to supplying well-established, "at risk" products to patients across multiple therapeutic areas, announces the appointment of Colin Brown as Chief Operating Officer. Colin has more than 35 years of experience in the p...

CMA secures affordable supply of key bipolar drug The CMA has accepted legally binding commitments from Essential Pharma to continue supplying a key bipolar drug at an affordable price for at least 5 years. From: 18 December 2020 In October, the CMA launched an investigation suspecting that the pharmaceutical supplier, Essential Pharma, may have abused a dominant market position by adopting a strategy to withdraw the bipolar drug, Priadel, from UK patients. This would have caused disruption...